Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2018 Dec 1;3(12):1222-1225.
doi: 10.1001/jamacardio.2018.3951.

Association of Rankings With Cardiovascular Outcomes at Top-Ranked Hospitals vs Nonranked Hospitals in the United States

Affiliations
Comparative Study

Association of Rankings With Cardiovascular Outcomes at Top-Ranked Hospitals vs Nonranked Hospitals in the United States

David E Wang et al. JAMA Cardiol. .

Erratum in

Abstract

Importance: The US News & World Report (USNWR) identifies the "Best Hospitals" for "Cardiology and Heart Surgery." These rankings may have significant influence on patients and hospitals.

Objective: To determine whether USNWR top-ranked hospitals perform better than nonranked hospitals on mortality rates and readmission measures as well as patient satisfaction.

Design, setting, and participants: This national retrospective study evaluated outcomes at 3552 US hospitals from 2014 to 2017.

Exposures: US News & World Report 2018 to 2019 Cardiology and Heart Surgery rankings (top-ranked vs nonranked hospitals).

Main outcomes and measures: Hospital-level 30-day risk-standardized mortality and readmission rates for Medicare fee-for-service beneficiaries age 65 years or older hospitalized for 3 cardiovascular conditions: acute myocardial infarction (AMI), heart failure (HF), and coronary artery bypass grafting (CABG) as well as Hospital Consumer Assessment of Healthcare Providers and Systems patient satisfaction star ratings obtained from publicly available Centers for Medicaid and Medicare Services data.

Results: Thirty-day mortality rates at top-ranked hospitals (n = 50), compared with nonranked hospitals (n = 3502), were lower for AMI (11.9% vs 13.2%, P < .001), HF (9.5% vs 11.9%; P < .001), and CABG (2.3%vs 3.3%; P < .001). Thirty-day readmission rates at the top-ranked hospitals (n = 50) when compared with nonranked hospitals (n = 2841) were similar for AMI (16.7% vs 16.5%; P = .64) and CABG (14.1% vs 13.7%; P = .15) but higher for HF (21.0% vs 19.2%; P < .001), Finally, patient satisfaction was higher at top-ranked hospitals (n = 50) compared with nonranked hospitals (n = 3412) (3.9 vs 3.3; P < .001).

Conclusions and relevance: We found that USNWR top-ranked hospitals for cardiovascular care had lower 30-day mortality rates for AMI, HF, and CABG and higher patient satisfaction ratings compared with nonranked hospitals. However, 30-day readmission rates were either similar (for AMI and CABG) or higher (for HF) at top-ranked compared with nonranked hospitals. This discrepancy between readmissions and other performance measures raises concern that readmissions may not be an adequate metric of hospital care quality.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Wadhera reported prior personal fees from Regeneron outside the submitted work. Dr Bhatt reported grants from Amarin, AstraZeneca, Bristol-Myers Squibb, Roche, Eisai, Ethicon, Medtronic, Sanofi Aventis, Pfizer, Forest Laboratories/AstraZeneca, Ischemix, Amgen, Lilly, Chiesi, Ironwood, Abbott, Regeneron, PhaseBio, Idorsia, Synaptic, and The Medicines Company; unfunded research support from FlowCo, PLx Pharma, Novo Nordisk, Takeda, and Merck; serving on the advisory boards of Medscape Cardiology, Regado Biosciences, Cardax; serving on the board of directors of Boston VA Research Institute; being the deputy editor of Clinical Cardiology; being a site coinvestigator for Biotronik, Boston Scientific, Svelte, and St Jude Medical (now Abbott); receiving honoraria from the American College of Cardiology; serving on clinical trial committees funded by Bayer and Boehringer Ingelheim; personal fees from Duke Clinical Research Institute, Mayo Clinic, Population Health Research Institute, Belvoir Publications, Slack Publications, WebMD, Elsevier, Society of Cardiovascular Patient Care, HMP Global, Harvard Clinical Research Institute (now Baim Institute for Clinical Research), Journal of the American College of Cardiology, Cleveland Clinic, Mount Sinai School of Medicine, and TobeSoft; nonfinancial support from American College of Cardiology, American Heart Association, and the Society of Cardiovascular Patient Care. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Mortality Rates and Readmission Rates at Top-Ranked vs Nonranked Hospitals
Thirty-day mortality rates (A) and readmission rate (B). AMI indicates acute myocardial infarction; HF, heart failure; CABG, coronary artery bypass grafting.
Figure 2.
Figure 2.. Patient Satisfaction Scores at Top-Ranked vs Nonranked Hospitals
Hospital Consumer Assessment of Healthcare Providers and Systems (HCAPHS) patient satisfaction star rating (1-5).

Similar articles

Cited by

References

    1. US News Best hospitals for cardiology & heart surgery. https://health.usnews.com/best-hospitals/rankings/cardiology-and-heart-s.... Accessed September 24, 2018.
    1. Sukul D, Bhatt DL, Seth M, et al. . Appropriateness and outcomes of percutaneous coronary intervention at top-ranked and nonranked hospitals in the United States. JACC Cardiovasc Interv. 2018;11(4):342-350. doi:10.1016/j.jcin.2017.10.042 - DOI - PubMed
    1. Wang OJ, Wang Y, Lichtman JH, Bradley EH, Normand SL, Krumholz HM. “America’s Best Hospitals” in the treatment of acute myocardial infarction. Arch Intern Med. 2007;167(13):1345-1351. doi:10.1001/archinte.167.13.1345 - DOI - PubMed
    1. Osborne NH, Nicholas LH, Ghaferi AA, Upchurch GR Jr, Dimick JB. Do popular media and internet-based hospital quality ratings identify hospitals with better cardiovascular surgery outcomes? J Am Coll Surg. 2010;210(1):87-92. doi:10.1016/j.jamcollsurg.2009.09.038 - DOI - PubMed
    1. Wadhera RK, Bhatt DL. Taking the “public” out of public reporting of percutaneous coronary intervention. JAMA. 2017;318(15):1439-1440. doi:10.1001/jama.2017.12087 - DOI - PMC - PubMed

Publication types

MeSH terms